Safety of rush immunotherapy using a modified schedule: a cumulative experience of 893 patients receiving multiple aeroallergens.

Conventional immunotherapy (IT) is effective in treating allergic rhinitis, allergic asthma, and chronic rhinosinusitis. Disadvantages include poor compliance, delayed efficacy, and patient frustration. Rush IT, or rapid desensitization, offers the advantages of rapid response, improved compliance, and cost-effectiveness.

Evaluating the response of patients undergoing both allergy skin testing and in vitro allergy testing with the ImmunoCAP Technology System.

Purpose: To evaluate the response of patients who underwent both skin and in vitro allergy testing, both of which are accepted methods.

Data Sources: Retrospective review of the case notes of 100 patients evaluated by both testing methods for allergic disease.

Conclusions: A total of 62 patients (62%) tested positive to at least one of the tested allergens via the in vitro method.